Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug
Dec. 7, 2017
| By Diane Mapes / Fred Hutch News Service
Results from a large multicenter trial released Thursday at the San Antonio Breast Cancer Symposium offer good news to early stage breast cancer patients dealing with painful side effects from powerful estrogen-squelching drugs known as aromatase inhibitors.
Study to examine how integrative medicine affects breast cancer outcomes
Aug. 2, 2010
The Fred Hutchinson Cancer Research Center and Bastyr University, a natural health sciences institution in Kenmore, Wash., received a joint $3.1 million grant for the study of complementary and integrative care for breast cancer from the National Institutes of Health and the National Center for Complementary and Alternative Medicine.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.